Literature DB >> 16889690

Effective chemopreventive activity of genistein against human breast cancer cells.

Yun-Hee Shon1, Sun-Dong Park, Kyung-Soo Nam.   

Abstract

Chemopreventive and cytotoxic effect of genistein against human breast cancer cell lines was investigated. Genistein inhibited cell proliferation in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) human breast carcinoma cell lines. Cytochrome P450 (CYP) 1A1-mediated ethoxyresorufin O-deethylase (EROD)activity was inhibited by genistein in a concentration-dependent manner. Genistein significantly inhibited 12-Otetradecanoylphorbol-13-acetate (TPA)-induced cyclooxygenase-2 activity and protein expression at the concentrations of 10 (p < 0.05), 25 (p < 0.05) and 50 mM (p < 0.01). In addition, ornithine decarboxylase (ODC) activity was reduced to 53.8 % of the control after 6 h treatment with 50 mM genistein in MCF-7 breast cancer cells. These results suggest that genistein could be of therapeutic value in preventing human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16889690     DOI: 10.5483/bmbrep.2006.39.4.448

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  19 in total

Review 1.  Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer.

Authors:  Shreena J Desai; Ben Prickril; Avraham Rasooly
Journal:  Nutr Cancer       Date:  2018-03-26       Impact factor: 2.900

2.  Genistein alters caffeine exposure in healthy female volunteers.

Authors:  Yao Chen; Chang-Qiong Xiao; Yi-Jing He; Bi-Lian Chen; Guo Wang; Gan Zhou; Wei Zhang; Zhi-Rong Tan; Shan Cao; Li-Ping Wang; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2010-12-14       Impact factor: 2.953

3.  Genistein at maximal physiologic serum levels induces G0/G1 arrest in MCF-7 and HB4a cells, but not apoptosis.

Authors:  Marcela S Tsuboy; Juliana C Marcarini; Alecsandra O de Souza; Natália A de Paula; Daniel J Dorta; Mário S Mantovani; Lucia R Ribeiro
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

4.  Effects of prior oral contraceptive use and soy isoflavonoids on estrogen-metabolizing cytochrome P450 enzymes.

Authors:  L M Scott; P Durant; S Leone-Kabler; C E Wood; T C Register; A Townsend; J M Cline
Journal:  J Steroid Biochem Mol Biol       Date:  2008-10-08       Impact factor: 4.292

5.  Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms.

Authors:  Yuanyuan Li; Liang Liu; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Int J Cancer       Date:  2009-07-15       Impact factor: 7.396

6.  Past oral contraceptive use and current dietary soy isoflavones influence estrogen metabolism in postmenopausal monkeys (Macaca fascicularis).

Authors:  Latanya M Scott; Xia Xu; Timothy D Veenstra; Janet A Tooze; Charles E Wood; Thomas C Register; Nancy D Kock; J Mark Cline
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

7.  Effects of the estrogen mimic genistein as a dietary component on sex differentiation and ethoxyresorufin-O-deethylase (EROD) activity in channel catfish (Ictalurus punctatus).

Authors:  C C Green; A M Kelly
Journal:  Fish Physiol Biochem       Date:  2008-09-06       Impact factor: 2.794

8.  Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A.

Authors:  Tara L Johnson; Maria B Lai; James C K Lai; Alok Bhushan
Journal:  Evid Based Complement Alternat Med       Date:  2008-02-29       Impact factor: 2.629

9.  Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.

Authors:  Yuanyuan Li; Syed M Meeran; Shweta N Patel; Huaping Chen; Tabitha M Hardy; Trygve O Tollefsbol
Journal:  Mol Cancer       Date:  2013-02-04       Impact factor: 27.401

10.  Epigenetic regulation of multiple tumor-related genes leads to suppression of breast tumorigenesis by dietary genistein.

Authors:  Yuanyuan Li; Huaping Chen; Tabitha M Hardy; Trygve O Tollefsbol
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.